Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib

ConclusionsThis study illustrates the patterns ofALK fusion variants present in Chinese NSCLC patients and might help explain heterogeneous clinical outcomes to crizotinib treatment according to differentALK fusion variants.

Source: Targeted Oncology - March 19, 2019 Category: Cancer & Oncology Source Type: research